BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 30125675)

  • 1. Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behcet's disease: A multicenter observational study of 18 patients.
    Desbois AC; Biard L; Addimanda O; Lambert M; Hachulla E; Launay D; Ackermann F; Pérard L; Hot A; Maurier F; Mausservey C; Bernard F; Noel N; Alric L; Mirault T; Cohen F; Boussouar S; Resche-Rigon M; Cacoub P; Saadoun D
    Clin Immunol; 2018 Dec; 197():54-59. PubMed ID: 30125675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of TNFα inhibitors for refractory vascular Behçet's disease: A multicenter observational study of 27 patients and a review of the literature.
    Aksoy A; Yazici A; Omma A; Cefle A; Onen F; Tasdemir U; Ergun T; Direskeneli H; Alibaz-Oner F
    Int J Rheum Dis; 2020 Feb; 23(2):256-261. PubMed ID: 31976619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and safety of anti-tumor necrosis factor α monoclonal antibodies in 16 patients with severe/refractory vasculo Behcet's disease].
    Li L; Liu JJ; Yu X; Wu D; Zhang SZ; Yang YJ; Zhou JX; Zeng XF; Zhang FC; Zheng WJ
    Zhonghua Nei Ke Za Zhi; 2020 Apr; 59(4):303-308. PubMed ID: 32209197
    [No Abstract]   [Full Text] [Related]  

  • 4. Budd-Chiari syndrome: a common complication of Behçet's disease.
    Bayraktar Y; Balkanci F; Bayraktar M; Calguneri M
    Am J Gastroenterol; 1997 May; 92(5):858-62. PubMed ID: 9149201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet's disease.
    Sugimura N; Mizoshita T; Sugiyama T; Togawa S; Miyaki T; Suzuki T; Tanida S; Kataoka H; Sasaki M
    Dig Liver Dis; 2019 Jul; 51(7):967-971. PubMed ID: 30872086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet's disease in Taiwan.
    Hu YC; Yang YH; Lin YT; Wang LC; Yu HH; Lee JH; Chiang BL
    BMC Pediatr; 2019 Jul; 19(1):232. PubMed ID: 31296171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behçet's disease; A rare refractory patient with vena cava superior syndrome treated with infliximab: a case report and review of the literature.
    Uyaroglu OA; Erden A; Kilic L; Peynircioğlu B; Karadag O; Kalyoncu U
    Acta Clin Belg; 2019 Oct; 74(5):364-369. PubMed ID: 30220250
    [No Abstract]   [Full Text] [Related]  

  • 8. Budd-Chiari syndrome associated with Behçet's disease.
    Ben Ghorbel I; Ennaifer R; Lamloum M; Khanfir M; Miled M; Houman MH
    Gastroenterol Clin Biol; 2008 Mar; 32(3):316-20. PubMed ID: 18400436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients.
    Vallet H; Riviere S; Sanna A; Deroux A; Moulis G; Addimanda O; Salvarani C; Lambert M; Bielefeld P; Seve P; Sibilia J; Pasquali J; Fraison J; Marie I; Perard L; Bouillet L; Cohen F; Sene D; Schoindre Y; Lidove O; Le Hoang P; Hachulla E; Fain O; Mariette X; Papo T; Wechsler B; Bodaghi B; Rigon MR; Cacoub P; Saadoun D;
    J Autoimmun; 2015 Aug; 62():67-74. PubMed ID: 26162757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease: An Observational Study.
    Desbois AC; Addimanda O; Bertrand A; Deroux A; Pérard L; Depaz R; Hachulla E; Lambert M; Launay D; Subran B; Ackerman F; Mariette X; Cohen F; Marie I; Salvarini C; Cacoub P; Saadoun D
    Medicine (Baltimore); 2016 Jun; 95(23):e3550. PubMed ID: 27281066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rare but serious manifestation of Behçet's disease: intracardiac thrombus in 22 patients.
    Emmungil H; Yaşar Bilge NŞ; Küçükşahin O; Kılıç L; Okutucu S; Gücenmez S; Kalyoncu U; Kaşifoğlu T; Turgay M; Aksu K
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S87-92. PubMed ID: 25068833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary artery involvement in Behçet׳s syndrome: Effects of anti-Tnf treatment.
    Hamuryudan V; Seyahi E; Ugurlu S; Melikoglu M; Hatemi G; Ozguler Y; Akman C; Tuzun H; Yurdakul S; Yazici H
    Semin Arthritis Rheum; 2015 Dec; 45(3):369-73. PubMed ID: 26190564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of adalimumab therapy for life-threatening pulmonary vasculitis in Behçet's disease.
    Aamar S; Peleg H; Leibowitz D; Chajek-Shaul T; Hiller N; Heyman SN
    Rheumatol Int; 2014 Jun; 34(6):857-60. PubMed ID: 23412691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of severe complications in Behçet's disease with TNF inhibitors.
    Desbois AC; Vallet H; Domont F; Comarmond C; Cacoub P; Saadoun D
    Expert Opin Biol Ther; 2017 Jul; 17(7):853-859. PubMed ID: 28503960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behçet's syndrome refractory to the conventional treatment modalities: a case series and review of the literature.
    Hatemi I; Hatemi G; Pamuk ON; Erzin Y; Celik AF
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S129-37. PubMed ID: 26486925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of sustained clinical response in patients with Behçet's disease-related uveitis treated with infliximab and adalimumab.
    Fabiani C; Vitale A; Rigante D; Emmi G; Lopalco G; Sota J; Vannozzi L; di Scala G; Guerriero S; Orlando I; Franceschini R; Capozzoli M; Frediani B; Galeazzi M; Iannone F; Tosi GM; Cantarini L
    Clin Rheumatol; 2018 Jun; 37(6):1715-1720. PubMed ID: 29671190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab in the treatment of Budd-Chiari syndrome in Behçet's disease.
    Santos LB; Rigueira J; Vilas AP
    Reumatismo; 2019 Oct; 71(3):163-165. PubMed ID: 31649380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis Network.
    Vallet H; Seve P; Biard L; Baptiste Fraison J; Bielefeld P; Perard L; Bienvenu B; Abad S; Rigolet A; Deroux A; Sene D; Perlat A; Marie I; Feurer E; Hachulla E; Fain O; Clavel G; Riviere S; Bouche PA; Gueudry J; Pugnet G; Le Hoang P; Resche Rigon M; Cacoub P; Bodaghi B; Saadoun D;
    Arthritis Rheumatol; 2016 Jun; 68(6):1522-30. PubMed ID: 27015607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budd-Chiari syndrome in Behçet's disease: a retrospective multicenter study.
    Akyol L; Toz B; Bayındır Ö; Zengin O; Cansu D; Yiğit M; Çetin GY; Omma A; Erden A; Küçükşahin O; Altuner MŞ; Çorba B; Ünal AU; Küçük H; Küçük A; Balkarli A; Gönüllü E; Tufan AN; Bakırcı S; Öner SY; Balcı MA; Kobak Ş; Yazıcı A; Özgen M; Şahin A; Koca SS; Erer B; Gül A; Aksu K; Keser G; Onat AM; Kısacık B; Kaşifoğlu T; Çefle A; Kalyoncu U; Sayarlıoğlu M
    Clin Rheumatol; 2022 Jan; 41(1):177-186. PubMed ID: 34368908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary artery aneurysms in Behçet's disease treated with anti-TNFα: A case series and review of the literature.
    Chan E; Sangle SR; Coghlan JG; D'Cruz DD
    Autoimmun Rev; 2016 Apr; 15(4):375-8. PubMed ID: 26777307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.